Inhibition of ELF3 confers synthetic lethality of PARP inhibitor in non-small cell lung cancer-Reference-Cited by-同舟云学术

Inhibition of ELF3 confers synthetic lethality of PARP inhibitor in non-small cell lung cancer

Published:2020-08-19 Issue:3 Volume:41 Page:304-311
ISSN:1079-9893
Container-title:Journal of Receptors and Signal Transduction
language:en
Short-container-title:Journal of Receptors and Signal Transduction

Author:

Wang Yan¹,Zuo Min¹,Jin Hongtao¹,Lai Meina¹,Luo Jinfeng¹,Cheng Zhiqiang¹

Affiliation:

1. Department of Pathology, Shenzhen People’s Hospital, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China

Publisher

Informa UK Limited

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/10799893.2020.1808676

Reference37 articles.

1. Nuclear PKCι-ECT2-Rac1 and Ribosome Biogenesis: A Novel Axis in Lung Tumorigenesis

2. PPAR Agonists for the Prevention and Treatment of Lung Cancer

3. Mutational Profiling of Second Primary Lung Cancers in Patients Who Have Received Radiation for the Treatment of Hodgkin's Disease

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical translation for targeting DNA damage repair in non-small cell lung cancer: a review;Translational Lung Cancer Research;2024-02

2. Comprehensive analysis of E47‑like factors and verification of ELF4 in clear cell renal cell carcinoma;Oncology Letters;2023-07-27

3. The ELF3 transcription factor is associated with an epithelial phenotype and represses epithelial-mesenchymal transition;Journal of Biological Engineering;2023-03-02

4. The ELF3 transcription factor is associated with an epithelial phenotype and represses epithelial-mesenchymal transition;2022-08-19

5. LINC00472 suppresses oral squamous cell carcinoma growth by targeting miR-455-3p/ELF3 axis;Bioengineered;2022-01-01